Literature DB >> 2951445

Equine leucocyte antigen system. IV. Recombination within the major histocompatibility complex (MHC).

S Lazary, M L Dubath, C Luder, H Gerber.   

Abstract

A case of recombination between the putative class I ELA antigen series and the structure(s) governing mixed lymphocyte reactivity in an informative horse family is described. The results of serological typing, 'lysostripping' and mixed lymphocyte culture tests strongly suggest that the recombination took place between two loci and is not intragenic. An alloantigenic membrane structure, provisionally called B1, which does not belong to the known ELA series, was also involved in the cross-over. The B1 antigen resembles the class II gene products of other species in two respects: it is not present on platelets, and alloantiserum with specificity for B1 inhibits the stimulatory effect of B1-carrying cells in mixed lymphocyte cultures. The B1 antigen does not follow the classical distribution, however, being expressed on both B and T lymphocytes. The finding of separate loci for the first series of ELA antigens and the MLR governing structure(s) demonstrates the similarity of the genetic organization of the horse MHC to that in other species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2951445     DOI: 10.1111/j.1744-313x.1986.tb01116.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  3 in total

1.  Polymorphism at expressed DQ and DR loci in five common equine MHC haplotypes.

Authors:  Donald Miller; Rebecca L Tallmadge; Matthew Binns; Baoli Zhu; Yasmin Ali Mohamoud; Ayeda Ahmed; Samantha A Brooks; Douglas F Antczak
Journal:  Immunogenetics       Date:  2016-11-26       Impact factor: 2.846

2.  Segregation distortion within the equine MHC; analogy to a mouse T/t-complex trait.

Authors:  E Bailey
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  The gene encoding the equine soluble class I molecule is linked to the horse MHC.

Authors:  A M Lew; E Bailey; R B Valas; J Coligan
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.